Aligos therapeutics to participate in the leerink partners global biopharma conference 2024

South san francisco, calif., feb. 26, 2024 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs, “aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that management will participate in one-on-one meetings at the leerink partners global biopharma conference 2024 being held in miami, florida on march 11-13, 2024.
ALGS Ratings Summary
ALGS Quant Ranking